MOG and demyelinating disease: Although both AQP4 and MOG antibody ON are antibody-mediated demyelinating diseases of the central nervous system, and both have pathogenic components of inflammation and neurodegeneration, the severity of the disease and the degree of pathogenic factors may differ between them.